Logo image of NUMI.CA

NUMINUS WELLNESS INC (NUMI.CA) Stock Price, Forecast & Analysis

Canada - Toronto Stock Exchange - TSX:NUMI - CA67054W1032 - Common Stock

0.05 CAD
+0.02 (+42.86%)
Last: 1/29/2025, 7:00:00 PM

NUMI.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap16.12M
Revenue(TTM)26.05M
Net Income(TTM)-29.86M
Shares322.32M
Float309.90M
52 Week High0.13
52 Week Low0.03
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.11
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO1982-08-10
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


NUMI.CA short term performance overview.The bars show the price performance of NUMI.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60

NUMI.CA long term performance overview.The bars show the price performance of NUMI.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of NUMI.CA is 0.05 CAD. In the past month the price increased by 25%. In the past year, price decreased by -58.33%.

NUMINUS WELLNESS INC / NUMI Daily stock chart

NUMI.CA Latest News, Press Relases and Analysis

NUMI.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
BHC.CA BAUSCH HEALTH COS INC 1.59 3.15B
TLRY.CA TILRAY BRANDS INC N/A 1.45B
CRON.CA CRONOS GROUP INC 23.93 1.28B
DHT-UN.CA DRI HEALTHCARE TRUST 7.67 918.91M
DHT-U.CA DRI HEALTHCARE TRUST 5.38 638.55M
GUD.CA KNIGHT THERAPEUTICS INC 122.4 610.04M
WEED.CA CANOPY GROWTH CORP N/A 527.67M
CPH.CA CIPHER PHARMACEUTICALS INC 21.69 357.01M
ACB.CA AURORA CANNABIS INC N/A 334.13M
HITI.CA HIGH TIDE INC N/A 322.75M
OGI.CA ORGANIGRAM GLOBAL INC N/A 283.44M
NGEN.CA NERVGEN PHARMA CORP N/A 293.64M

About NUMI.CA

Company Profile

NUMI logo image Numinus Wellness, Inc. engages in the development of psychedelic-centered therapeutic products. The company is headquartered in Montreal, Quebec. The firm focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training segment is engaged in education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network segment includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. Corporate segment includes finance, marketing, information technology, legal, and human resources.

Company Info

NUMINUS WELLNESS INC

393 Laurier Ave W

MONTREAL QUEBEC V6B 1R4 CA

CEO: Payton Nyquvest

Employees: 0

NUMI Company Website

NUMI Investor Relations

Phone: 18336864687.0

NUMINUS WELLNESS INC / NUMI.CA FAQ

What does NUMINUS WELLNESS INC do?

Numinus Wellness, Inc. engages in the development of psychedelic-centered therapeutic products. The company is headquartered in Montreal, Quebec. The firm focuses on advancing traditional and behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies. Its segments include Clinical research operations, Practitioner Training, Clinic network, and Corporate. Clinical research operations segment is focused on licensed psychedelic research and provides clinical research management services to academic institutions and biotechnology companies. Practitioner Training segment is engaged in education and training for research and drug development organizations to support clinical trials and commercialization efforts. Clinic network segment includes wellness clinics, which is engaged in providing clinical services from psychedelic-assisted therapies, transcranial magnetic stimulation, and psychiatric and medical model management. Corporate segment includes finance, marketing, information technology, legal, and human resources.


What is the current price of NUMI stock?

The current stock price of NUMI.CA is 0.05 CAD. The price increased by 42.86% in the last trading session.


Does NUMI stock pay dividends?

NUMI.CA does not pay a dividend.


What is the ChartMill technical and fundamental rating of NUMI stock?

NUMI.CA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Can you provide the PE ratio for NUMI stock?

NUMINUS WELLNESS INC (NUMI.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.11).


What is the employee count for NUMI stock?

NUMINUS WELLNESS INC (NUMI.CA) currently has 0 employees.


What is the market capitalization of NUMI stock?

NUMINUS WELLNESS INC (NUMI.CA) has a market capitalization of 16.12M CAD. This makes NUMI.CA a Nano Cap stock.


NUMI.CA Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to NUMI.CA. When comparing the yearly performance of all stocks, NUMI.CA turns out to be only a medium performer in the overall market: it outperformed 45.79% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

NUMI.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to NUMI.CA. NUMI.CA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NUMI.CA Financial Highlights

Over the last trailing twelve months NUMI.CA reported a non-GAAP Earnings per Share(EPS) of -0.11. The EPS increased by 37.67% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -213.24%
ROE -644.74%
Debt/Equity 0.95
Chartmill High Growth Momentum
EPS Q2Q%35.87%
Sales Q2Q%-27.88%
EPS 1Y (TTM)37.67%
Revenue 1Y (TTM)22.69%

NUMI.CA Forecast & Estimates

For the next year, analysts expect an EPS growth of 58.33% and a revenue growth -18.04% for NUMI.CA


Analysts
Analysts82.86
Price TargetN/A
EPS Next Y58.33%
Revenue Next Year-18.04%

NUMI.CA Ownership

Ownership
Inst Owners2.66%
Ins Owners3.55%
Short Float %N/A
Short RatioN/A